Journal Logo

Articles by O. H. E. Fagerholt

SINGLE CELL SIGNALING PHARMACODYNAMICS IN A PHASE 1B CLINICAL TRIAL OF THE AXL INHIBITOR BEMCENTINIB IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME: PS999

Hellesøy, M.; Fagerholt, O. H. E.; Tislevoll, B. S.; More

HemaSphere. 3:449-450, June 2019.